Contents:
Death rates began declining in men in , and between to rates decreased by 2. Lung cancer mortality rates for women was most recently reported to be Globally, lung cancer is the most common cause of death from cancer, with 1. The overall 5-year survival rate for lung cancer of all stages was This rate has slightly improved over time, compared with a Although the overall prognosis for lung cancer remains poor, women have better survival compared with men across all ages, irrespective of histologic subtype.
Although the smoking prevalence among women in the United States has been stable for the past few years, the U. Important differences exist among men and women with lung cancer. Controversy exists as to whether women are more or less susceptible to the carcinogenic effects of cigarette smoke. Several studies have argued that women are more vulnerable to tobacco carcinogens than men.
This phenomenon suggests a role for estrogen signaling. Cigarette smoking is by far the most important risk factor in the development of lung cancer. There are at least two ways that smoking is associated with lung cancer. First, polycyclic aromatic hydrocarbons, carcinogenic compounds present in tobacco smoke, induce mutations in the p53 gene that are crucial for cell cycle dysregulation and carcinogenesis.
Second, the N-nitroso compounds are another major group of chemicals found in tobacco smoke, several of which are potent animal carcinogens. These compounds can be found in the urine of smokers. Over the past few decades, the incidence of adenocarcinoma of the lung increased much more rapidly than that of squamous cell carcinoma in men and women. These deeper and more frequent inhalations, described as compensatory smoking, can result in increased distribution of carcinogens to the periphery of the lung and the increased prevalence of adenocarcinoma. Environmental Protection Agency has determined radon to be the second leading cause of lung cancer after cigarette smoking.
High radon concentrations have been linked to an increased risk of lung cancer in underground miners.
National committees and organizations have concluded that exposure to environmental tobacco smoke is a cause of lung cancer. Exposure to asbestos at high levels can cause lung cancer and mesothelioma. Because mesothelioma is so rare, asbestos-induced cases of lung cancer significantly outnumber cases of mesothelioma among asbestos-exposed workers. Other environmental agents that have been associated with lung cancer are radon, silica, chromium, cadmium, nickel, arsenic, and beryllium.
This risk of developing a second primary lung cancer can translate into an important cumulative risk and is a common cause of death in lung cancer survivors. Lung cancer risk is also higher in the human immunodeficiency virus HIV -infected population than in the general population, and it is the most common non-acquired immunodeficiency syndrome defining malignancy.
Studies have also shown a marked increased risk of lung cancer in breast cancer survivors treated with radiotherapy who smoke cigarettes. The combination of smoking and radiation exposure enhances the risk of lung cancer compared with radiation exposure in nonsmoking breast cancer survivors. A detailed analysis of patients who received extensive postmastectomy radiation to the chest wall and regional lymphatic node areas were shown to have a greater risk of developing lung cancer than patients who had undergone more conservative postlumpectomy breast irradiation.
Preventing initiation of tobacco use is a public health priority.
Mutational profiling of lung tumors has demonstrated distinct somatic mutations that can be used as molecular targets and biomarkers of response to anticancer agents: EGFR is a tyrosine kinase receptor commonly altered in epithelial tumors. Many tumors demonstrate increased activity of the EGFR ; resultant amplification of the EGFR signaling pathway drives cell proliferation and tumor growth. In those patients with EGFR mutations, progression-free survival after receiving gefitinib was twice that of patients without an EGFR mutation, thus identifying a group that would benefit from tyrosine kinase inhibition.
Although EGFR mutations are more common in Asian populations, the therapeutic effect of tyrosine kinase inhibition in a non-Asian population with EGFR mutations was also observed when erlotinib was compared with chemotherapy as a first-line treatment for European patients with advanced lung cancer. Unlike EGFR mutations, KRAS mutations show no sex predilection, are more frequent in white populations than Asians, and are most commonly identified in former or current cigarette smokers.
ALK encodes a receptor tyrosine kinase. Patients with ALK rearrangements tend to be younger than those without the rearrangement, have little or no exposure to tobacco, and have adenocarcinoma histology. Mutations in EGFR and ALK rearrangements are typically not present in squamous cell lung carcinoma, and targeted agents developed for adenocarcinoma are therefore largely ineffective against squamous cell carcinoma. Lung cancer is unique among leading cancers in that it has an obvious environmental etiology and therefore the potential for risk reduction.
Because disease control efforts throughout the world have plateaued, lung cancer is likely to remain the world's leading cause of cancer-related disease burden. Smoking cessation programs should remain an important aspect of the long term efforts to reduce the incidence of lung cancer.
The elucidation in recent years of individual genetic susceptibility for lung cancer has been a step forward in the understanding of lung cancer biology, facilitating development of targeted therapies and providing prognostic predictors of treatment response and outcome. National Center for Biotechnology Information , U. Journal List Semin Intervent Radiol v.
Ginsberg , MD 1. Author information Copyright and License information Disclaimer. Address for correspondence Michelle S. This article has been cited by other articles in PMC. Abstract Incidence and mortality attributed to lung cancer has risen steadily since the s. History Incidence and mortality attributed to lung cancer has risen steadily since the s, predominantly due to the popularity of cigarette smoking. Incidence Six million new cases of lung cancer, or Mortality Lung cancer has been the leading cause of cancer deaths among men since the early s, and in it surpassed breast cancer to become the leading cause of cancer deaths among women in the United States.
Women and Lung Cancer Although the smoking prevalence among women in the United States has been stable for the past few years, the U. Risk Factors Tobacco Cigarette smoking is by far the most important risk factor in the development of lung cancer. Secondhand Smoke Exposure and Other Environmental Factors National committees and organizations have concluded that exposure to environmental tobacco smoke is a cause of lung cancer. Tobacco Use Trends Preventing initiation of tobacco use is a public health priority.
Conclusion Lung cancer is unique among leading cancers in that it has an obvious environmental etiology and therefore the potential for risk reduction. Primary malignant growths of the lungs and bronchi.
Basic Cancer Facts. Figure 1. Estimated Number of Deaths for Selected Cancers Surveillance, Epidemiology, and End Results (SEER). Cancer Facts & Figures is an educational companion for Cancer Statistics , a scientific paper published in the American Cancer Society journal, CA: A .
Harting F H, Hesse W. Der Lungenkrebs, die Bergenkrankheit in den Schneeberger gruben. Ochsner A, DeBakey M. Treatment by total pneumonectomy, analysis of 70 collected cases and presentation of 7 personal cases. Doll R, Hill A B. Smoking and carcinoma of the lung; preliminary report. Royal College of Physicians.
Royal College of Physicians; A report on smoking in relation to lung cancer and other diseases. Department of Health, Education, and Welfare; Department of Health, Education, and Welfare. Public Health Service; Publication No. The Health Consequences of Smoking. International Agency for Research on Cancer; Bethesda, MD Available at: Accessed October 15, The International Epidemiology of Lung Cancer: Patterns of cancer incidence, mortality, and prevalence across five continents: Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe.
International lung cancer trends by histologic type: Twenty-year secular changes in sex specific lung cancer incidence rates in an urban Chinese population. Our Family Of Sites. Select your location to view local American Lung Association information near you Enter your zipcode. Lung Cancer Fact Sheet Below are facts and statistics on lung cancer, looking at trends in mortality, prevalence, gender and racial differences, survival rate and burden i.
Lung cancer is the leading cancer killer in both men and women in the U. In , it surpassed breast cancer to become the leading cause of cancer deaths in women. It is similar for blacks However, black men have a far higher age-adjusted lung cancer death rate than white men, while black and white women have similar rates. Lung cancer is mostly a disease of the elderly. In , 86 percent of those living with lung cancer were 60 years of age or older.
Utah had the lowest age-adjusted cancer incidence rates in both men and women Lung cancer is the most common cancer worldwide, accounting for 2. More men are diagnosed with lung cancer each year, but more women live with the disease. The rate of new cases in showed that men develop lung cancer more often than women In , rates were low for women, but rising for both men and women. In , the rate of new cases for men peaked The rate of new cases for women increased further, did not peak until The age-adjusted lung cancer incidence rate among black men is approximately 30 percent higher than for white men, even though their overall exposure to cigarette smoke, the primary risk factor for lung cancer, is lower.
What Does Survival Rate Mean? Screening and Early Detection. Screening for individuals at high risk has the potential to dramatically improve lung cancer survival rates by finding the disease at an earlier stage when it is more likely to be curable. Early detection, by low-dose CT screening, can decrease lung cancer mortality by 14 to 20 percent among high-risk populations.
Smoking , a main cause of small cell and non-small cell lung cancer, contributes to 80 percent and 90 percent of lung cancer deaths in women and men, respectively. Men who smoke are 23 times more likely to develop lung cancer. Women are 13 times more likely, compared to never smokers.
Because of the interactions between exposures, the combined attributable risk for lung cancer can exceed percent. Radon is a tasteless, colorless and odorless gas that is produced by decaying uranium and occurs naturally in soil and rock. The majority of these deaths occur among smokers since there is a greater risk for lung cancer when smokers also are exposed to radon.